Patents by Inventor John Kevin Collins

John Kevin Collins has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Canine probiotic bifidobacterium pseudolongum
    Patent number: 9580680
    Abstract: According to the invention there is provided a strain of lactic acid bacteria of the species Bifidobacterium pseudolongum obtainable by isolation from resected and washed canine gastrointestinal tract having a probiotic activity in animals. Methods of use and compositions comprising the Bifidobacterium pseudolongum of the present invention are also provided.
    Type: Grant
    Filed: November 13, 2008
    Date of Patent: February 28, 2017
    Assignee: Mars, Incorporated
    Inventors: Thomas William-Maxwell Boileau, Michael Anthony Ceddia, John Kevin Collins, Gary Mitchell Davenport, Barry Pius Kiely, Liam Diarmuid O'Mahony, Gregory Dean Sunvold, Mark Alan Tetrick, Robert Jason Vickers
  • CANINE PROBIOTIC LACTOBACILLI
    Publication number: 20160002590
    Abstract: According to the invention there is provided a strain of lactic acid bacteria of the genus Lactobacilli obtainable by isolation from resected and washed canine gastrointestinal tract having a probiotic activity in animals. Methods of use and compositions comprising the Lactobacilli of the present invention are also provided.
    Type: Application
    Filed: September 29, 2014
    Publication date: January 7, 2016
    Inventors: Thomas William-Maxwell Boileau, Michael Anthony Ceddia, Gary Mitchell Davenport, Barry Pius Kiely, Liam Diarmuid O'Mahony, Gregory Dean Sunvold, Mark Alan Tetrick, Robert Jason Vickers, John Kevin Collins
  • Method of treating diarrhea in a canine
    Patent number: 8900568
    Abstract: According to the invention there is provided a strain of lactic acid bacteria of the species Bifidobacteria pseudolongum obtainable by isolation from resected and washed canine gastrointestinal tract having a probiotic activity in animals. Methods of use and compositions comprising the Bifidobacteria pseudolongum of the present invention are also provided.
    Type: Grant
    Filed: April 18, 2008
    Date of Patent: December 2, 2014
    Assignees: The Iams Company, Alimentary Health, Ltd.
    Inventors: Thomas William-Maxwell Boileau, Michael Anthony Ceddia, John Kevin Collins, Gary Mitchell Davenport, Barry Pius Kiely, Liam Diarmuid O'Mahony, Gregory Dean Sunvold, Mark Alan Tetrick, Robert Jason Vickers
  • Method of treating diarrhea in a canine
    Patent number: 8900569
    Abstract: According to the invention there is provided a strain of lactic acid bacteria of the species Bifidobacteria globosum obtainable by isolation from resected and washed canine gastrointestinal tract having a probiotic activity in animals. Methods of use and compositions comprising the Bifidobacteria globosum of the present invention are also provided.
    Type: Grant
    Filed: April 18, 2008
    Date of Patent: December 2, 2014
    Assignees: The Iams Company, Alimentary Health
    Inventors: Thomas William-Maxwell Boileau, Michael Anthony Ceddia, John Kevin Collins, Gary Mitchell Davenport, Barry Pius Kiely, Liam Diarmuid O'Mahony, Gregory Dean Sunvold, Mark Alan Tetrick, Robert Jason Vickers
  • Canine probiotic
    Patent number: 8894991
    Abstract: According to the invention there is provided a strain of lactic acid bacteria of the genus Lactobacilli obtainable by isolation from resected and washed canine gastrointestinal tract having a probiotic activity in animals. Methods of use and compositions comprising the Lactobacilli of the present invention are also provided.
    Type: Grant
    Filed: December 15, 2004
    Date of Patent: November 25, 2014
    Assignee: The Iams Company
    Inventors: Thomas William-Maxwell Boileau, Michael Anthony Ceddia, John Kevin Collins, Gary Mitchell Davenport, Barry Pius Kiely, Liam Diarmuid O'Mahony, Gregory Dean Sunvold, Mark Alan Tetrick, Robert Jason Vickers
  • Canine probiotic bifidobacteria globosum
    Patent number: 8840880
    Abstract: According to the invention there is provided a strain of lactic acid bacteria of the species Bifidobacteria globosum obtainable by isolation from resected and washed canine gastrointestinal tract having a probiotic activity in animals. Methods of use and compositions comprising the Bifidobacteria globosum of the present invention are also provided.
    Type: Grant
    Filed: November 3, 2008
    Date of Patent: September 23, 2014
    Assignees: The Iams Company, Alimentary Health, Ltd.
    Inventors: Thomas William-Maxwell Boileau, Michael Anthony Ceddia, John Kevin Collins, Gary Mitchell Davenport, Barry Pius Kiely, Liam Diarmuid O'Mahony, Gregory Dean Sunvold, Mark Alan Tetrick, Robert Jason Vickers
  • Canine probiotic
    Patent number: 8809035
    Abstract: According to the invention there is provided a strain of lactic acid bacteria of the species Bifidobacterium globosum obtainable by isolation from resected and washed canine gastrointestinal tract having a probiotic activity in animals. Methods of use and compositions comprising the Bifidobacterium globosum of the present invention are also provided.
    Type: Grant
    Filed: October 31, 2008
    Date of Patent: August 19, 2014
    Assignees: The Iams Company, Alimentary Health, Ltd.
    Inventors: Thomas William-Maxwell Boileau, Michael Anthony Ceddia, John Kevin Collins, Gary Mitchell Davenport, Barry Pius Kiely, Liam Diarmuid O'Mahony, Gregory Dean Sunvold, Mark Alan Tetrick, Robert Jason Vickers
  • METHODS OF DETERMINING EFFICACY OF TREATMENTS OF DISEASES OF THE BOWEL
    Publication number: 20130217600
    Abstract: Novel methods of determining efficacy of a treatment of inflammatory diseases of the bowel in mammals are provided. The methods are of use in screening and determining the efficacy of treatments of inflammatory diseases of the bowel, and for determining the efficacy response of individual sufferers of inflammatory diseases of the bowel to a given regime. Kits for carrying out the method are also provided.
    Type: Application
    Filed: June 15, 2012
    Publication date: August 22, 2013
    Inventors: Ker-Sang Chen, John Kevin Collins, Barry Pius Kiely, Fangyi Luo, Liam Diarmuid O'Mahony, Ross Peter Phillipson, Fergus Shanahan
  • Methods of determining efficacy of treatments of diseases of the bowel
    Patent number: 8216563
    Abstract: Novel methods of determining efficacy of a treatment of inflammatory diseases of the bowel in mammals are provided. The methods are of use in screening and determining the efficacy of treatments of inflammatory diseases of the bowel, and for determining the efficacy response of individual sufferers of inflammatory diseases of the bowel to a given regime. Kits for carrying out the method are also provided.
    Type: Grant
    Filed: February 28, 2011
    Date of Patent: July 10, 2012
    Assignee: The Procter & Gamble Company
    Inventors: Ker-Sang Chen, John Kevin Collins, Barry Pius Kiely, Fangyi Luo, Liam Diarmuid O'Mahony, Ross Peter Phillipson, Fergus Shanahan
  • Methods of treatment or prevention of gastrointestinal disorders using canine probiotic bifidobacterium
    Patent number: 7998473
    Abstract: According to the invention there is provided a strain of lactic acid bacteria of the species Bifidobacteria pseudolongum obtainable by isolation from resected and washed canine gastrointestinal tract having a probiotic activity in animals. Methods of use and compositions comprising the Bifidobacteria pseudolongum of the present invention are also provided.
    Type: Grant
    Filed: November 14, 2008
    Date of Patent: August 16, 2011
    Assignee: The Procter & Gamble Company
    Inventors: Thomas William-Maxwell Boileau, Michael Anthony Ceddia, John Kevin Collins, Gary Mitchell Davenport, Barry Pius Kiely, Liam Diarmuid O'Mahony, Gregory Dean Sunvold, Mark Alan Tetrick, Robert Jason Vickers
  • METHODS OF DETERMINING EFFICACY OF TREATMENTS OF DISEASES OF THE BOWEL
    Publication number: 20110152117
    Abstract: Novel methods of determining efficacy of a treatment of inflammatory diseases of the bowel in mammals are provided. The methods are of use in screening and determining the efficacy of treatments of inflammatory diseases of the bowel, and for determining the efficacy response of individual sufferers of inflammatory diseases of the bowel to a given regime. Kits for carrying out the method are also provided.
    Type: Application
    Filed: February 28, 2011
    Publication date: June 23, 2011
    Inventors: Ker-Sang Chen, John Kevin Collins, Barry Pius Kiely, Fangyi Luo, Liam Diarmuid O'Mahony, Ross Peter Phillipson, Fergus Shanahan
  • Methods of determining efficacy of treatments of inflammatory diseases of the bowel
    Patent number: 7923000
    Abstract: Novel methods of determining efficacy of a treatment of inflammatory diseases of the bowel in mammals are provided. The methods are of use in screening and determining the efficacy of treatments of inflammatory diseases of the bowel, and for determining the efficacy response of individual sufferers of inflammatory diseases of the bowel to a given regime. Kits for carrying out the method are also provided.
    Type: Grant
    Filed: March 26, 2004
    Date of Patent: April 12, 2011
    Assignee: The Procter & Gamble Company
    Inventors: Ker-Sang Chen, John Kevin Collins, Barry Pius Kiely, Fangyi Luo, Liam Diarmuid O'Mahony, Ross Peter Phillipson, Fergus Shanahan
  • Canine probiotic
    Patent number: 7906112
    Abstract: According to the invention there is provided a strain of lactic acid bacteria of the genus Lactobacilli obtainable by isolation from resected and washed canine gastrointestinal tract having a probiotic activity in animals. Methods of use and compositions comprising the Lactobacilli of the present invention are also provided.
    Type: Grant
    Filed: April 18, 2008
    Date of Patent: March 15, 2011
    Assignee: The Procter & Gamble Company
    Inventors: Thomas William-Maxwell Boileau, Michael Anthony Ceddia, John Kevin Collins, Gary Mitchell Davenport, Barry Pius Kiely, Liam Diarmuid O'Mahony, Gregory Dean Sunvold, Mark Alan Tetrick, Robert Jason Vickers
  • BIFIDOBACTERIUM IN THE TREATMENT OF INFLAMMATORY DISEASE
    Publication number: 20100112003
    Abstract: A strain of Bifidobacterium isolated from resected and washed human gastrointestinal tract is significantly immunomodulatory following oral consumption in humans. The strain is useful in the prophylaxis and/or treatment of undesirable inflammatory activity, especially gastrointestinal inflammatory activity such as inflammatory bowel disease or irritable bowel syndrome. The inflammatory activity may also be due to cancer.
    Type: Application
    Filed: June 5, 2009
    Publication date: May 6, 2010
    Inventors: John Kevin Collins, Gerald Christopher O'Sullivan, Liam O'Mahony, Fergus Shanahan
  • Canine probiotic bifidobacteria globosum
    Publication number: 20090169515
    Abstract: According to the invention there is provided a strain of lactic acid bacteria of the species Bifidobacteria pseudolongum obtainable by isolation from resected and washed canine gastrointestinal tract having a probiotic activity in animals. Methods of use and compositions comprising the Bifidobacteria pseudolongum of the present invention are also provided.
    Type: Application
    Filed: October 31, 2008
    Publication date: July 2, 2009
    Applicant: The IAMS Company
    Inventors: Thomas William-Maxwell Boileau, Michael Anthony Ceddia, John Kevin Collins, Gary Mitchell Davenport, Barry Pius Kiely, Liam Diarmuid O'Mahony, Gregory Dean Sunvold, Mark Alan Tetrick, Robert Jason Vickers
  • CANINE PROBIOTIC BIFIDOBACTERIA GLOBOSUM
    Publication number: 20090148409
    Abstract: According to the invention there is provided a strain of lactic acid bacteria of the species Bifidobacteria globosum obtainable by isolation from resected and washed canine gastrointestinal tract having a probiotic activity in animals. Methods of use and compositions comprising the Bifidobacteria globosum of the present invention are also provided.
    Type: Application
    Filed: November 3, 2008
    Publication date: June 11, 2009
    Inventors: Thomas William-Maxwell Boileau, Michael Anthony Ceddia, John Kevin Collins, Gary Mitchell Davenport, Barry Pius Kiely, Liam Diarmuid O'Mahony, Gregory Dean Sunvold, Mark Alan Tetrick, Robert Jason Vickers
  • CANINE PROBIOTIC BIFIDOBACTERIA PSEUDOLONGUM
    Publication number: 20090148410
    Abstract: According to the invention there is provided a strain of lactic acid bacteria of the species Bifidobacteria pseudolongum obtainable by isolation from resected and washed canine gastrointestinal tract having a probiotic activity in animals. Methods of use and compositions comprising the Bifidobacteria pseudolongum of the present invention are also provided.
    Type: Application
    Filed: November 14, 2008
    Publication date: June 11, 2009
    Inventors: Thomas William-Maxwell Boileau, Michael Anthony Ceddia, John Kevin Collins, Gary Mitchell Davenport, Barry Pius Kiely, Liam Diarmuid O'Mahony, Gregory Dean Sunvold, Mark Alan Tetrick, Robert Jason Vickers
  • Canine probiotic bifidobacteria pseudolongum
    Publication number: 20090136455
    Abstract: According to the invention there is provided a strain of lactic acid bacteria of the species Bifidobacteria pseudolongum obtainable by isolation from resected and washed canine gastrointestinal tract having a probiotic activity in animals. Methods of use and compositions comprising the Bifidobacteria pseudolongum of the present invention are also provided.
    Type: Application
    Filed: November 13, 2008
    Publication date: May 28, 2009
    Inventors: Thomas William-Maxwell Boileau, Michael Anthony Ceddia, John Kevin Collins, Gary Mitchell Davenport, Barry Pius Kiely, Liam Diarmuid O'Mahony, Gregory Dean Sunvold, Mark Alan Tetrick, Robert Jason Vickers
  • Canine probiotic bifidobacteria pseudolongum
    Publication number: 20090092585
    Abstract: According to the invention there is provided a strain of lactic acid bacteria of the species Bifidobacteria pseudolongum obtainable by isolation from resected and washed canine gastrointestinal tract having a probiotic activity in animals. Methods of use and compositions comprising the Bifidobacteria pseudolongum of the present invention are also provided.
    Type: Application
    Filed: April 18, 2008
    Publication date: April 9, 2009
    Inventors: Thomas William-Maxwell Boileau, Michael Anthony Ceddia, John Kevin Collins, Gary Mitchell Davenport, Barry Pius Kiely, Liam Diarmuid O'Mahony, Gregory Dean Sunvold, Mark Alan Tetrick, Robert Jason Vickers
  • Canine probiotic Bifidobacteria globosum
    Publication number: 20090010893
    Abstract: According to the invention there is provided a strain of lactic acid bacteria of the species Bifidobacteria globosum obtainable by isolation from resected and washed canine gastrointestinal tract having a probiotic activity in animals. Methods of use and compositions comprising the Bifidobacteria globosum of the present invention are also provided.
    Type: Application
    Filed: April 18, 2008
    Publication date: January 8, 2009
    Inventors: Thomas William-Maxwell Boileau, Michael Anthony Ceddia, John Kevin Collins, Gary Mitchell Davenport, Barry Pius Kiely, Liam Diarmuid O'Mahony, Gregory Dean Sunvold, Mark Alan Tetrick, Robert Jason Vickers